FULCRUM THERAPEUTICS

Lobbying client · Massachusetts · filed 2025 to 2026

Rare disease biopharma company

$270,000 Reported spend

7 Filings counted

1 Outside firm hired

4 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (63679), filed by the registrant listed below.

Who filed for this client 1

THE MCMANUS GROUP $270,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 4

H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…

6 filings
S. 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…

6 filings
H.R. 1262
Mikaela Naylon Give Kids a Chance Act

2 filings
S. 932
Give Kids a Chance Act of 2025

2 filings

Reported by year 2 years

2026 $110,000 2 filings
2025 $160,000 5 filings

Issues lobbied 1

Health Issues 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 7 total

Q2 termination

THE MCMANUS GROUP

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1 report

THE MCMANUS GROUP

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026

View → Q4 report

THE MCMANUS GROUP

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 20, 2026

View → Q3 report

THE MCMANUS GROUP

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2 report

THE MCMANUS GROUP

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 21, 2025

View → Q1 report

THE MCMANUS GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted May 6, 2025

View → Registration

THE MCMANUS GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · posted Jan 17, 2025

View →

Affiliated organisations 1

FULCRUM THERAPEUTICS United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Keep going

Filings through July 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.